Table 5. Interventional and pharmacological therapies during hospitalization of NSTE-ACS patients.
Registry 1 (2008-2010) | Registry 2 (2012-2015) | p value | |
(n = 975) | (n = 1062) | ||
Interventional therapies | |||
Door to ECG time (min) | 13 (7-31) | 9 (5-75) | 0.4834 |
First ECG within 10 min | 35.9% | 48.5% | < 0.0001 |
D2B time (min) | 2534 (260-3367) | 2003 (1016-4167) | 0.0048 |
Left main intervention | 3.8% | 5.6% | 0.0496 |
No. of lesion treated > 2 | 12.6% | 22.2% | < 0.0001 |
DES | 35.1% | 62.9% | < 0.0001 |
CABG | 0.9% | 0.3% | 0.0598 |
Pharmacological therapies | |||
Aspirin | 89.7% | 99.3% | < 0.0001 |
Clopidogrel | 93.3% | 99.6% | < 0.0001 |
Dual antiplatelet therapy | 85.5% | 99.0% | < 0.0001 |
GP 2b3a inhibitor | 9.1% | 8.5% | 0.6027 |
Heparin | 65.5% | 85.5% | < 0.0001 |
ACEI/ARB | 58.3% | 67.6% | < 0.0001 |
Beta blocker | 43.3% | 64.4% | < 0.0001 |
Statin | 48.0% | 78.8% | < 0.0001 |
Calcium channel antagonist | 15.3% | 26.2% | < 0.0001 |
Nitrate | 69.3% | 59.8% | < 0.0001 |
Oral anticoagulant | 0.6% | 3.7% | < 0.0001 |
Abbreviations as the Table 2.